Lilly CEO Taurel Passes Baton To Lechleiter Effective April 1
This article was originally published in The Pink Sheet Daily
Executive Summary
As president and chief operating officer since October 2005, Lechleiter has been groomed for the post.
You may also be interested in...
Lilly, Daiichi Explore Pharmacogenomic Marker For Prasugrel
A May 4 Circulation article describing prasugrel's efficacy in patients who carry a genetic marker indicative of non-response to Plavix may be the opening volley in one of the first big marketing battles of the personalized medicine era
Lilly, Daiichi Explore Pharmacogenomic Marker For Prasugrel
A May 4 Circulation article describing prasugrel's efficacy in patients who carry a genetic marker indicative of non-response to Plavix may be the opening volley in one of the first big marketing battles of the personalized medicine era
Daiichi Sankyo, Lilly Explore Pharmacogenomic Marker For Prasugrel
A May 4 Circulation article describing prasugrel's efficacy in patients who carry a genetic marker indicative of non-response to Plavix may be the opening volley in one of the first big marketing battles of the personalized medicine era